Holding(s) in Company
Julian Hanton, through Hargreaves Lansdown (Nominees) Limited and Pershing Nominees Limited, has acquired a holding in Cambridge Nutritional Sciences Plc, resulting in a notification of major holdings. As of October 5, 2026, this acquisition means the total voting rights held amount to 3.004825%, representing 7,150,000 voting rights attached to shares. This notification was made on October 7, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your CNSL notes
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : | Cambridge Nutritional Sciences Plc |
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Julian Hanton |
City and country of registered office (if applicable)
Full name of shareholder(s) (if different from 3.) v
| Name | Hargreaves Lansdown (Nominees) Limited, Pershing Nominees Limited |
| City and country of registered office (if applicable) | Bristol, UK, Liverpool, UK |
| 5. Date on which the threshold was crossed or reached vi : | 05/10/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 07/10/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 3.004825 | 3.004825 | 7,150,000 |
| Position of previous notification (if applicable) | |||
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| GB00B1VCP282 | 7,150,000 | 3.004825 | |
| SUBTOTAL 8. A | 7,150,000 | 3.004825 | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | UK |
| Date of completion | 07/10/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.